In our current study, we found elevated CD40 expression in MOSE-II cells compared with MOSE-I cells; however, CD40 expression was reduced in ovarian cancer tissues, which is opposite the findings of a previous study (Zhou et al., 2012). The gene discussed is CD40; the disease is ovarian carcinoma.